SEMAX 5/10mg

(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY) 

Semax

is a synthetic nootropic and neuroprotective peptide developed in Russia that enhances cognitive function and protects brain tissue. It is an approved medication in Russia but remains an investigational "research chemical" in the United States and Europe. 

Mechanism of Action

Semax, a heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH), influences the brain's internal regulatory processes without hormonal activity. 

• BDNF Stimulation: It rapidly elevates levels of brain-derived neurotrophic factor (BDNF), a protein vital for neuron survival, growth, and synaptic plasticity (the brain's ability to form new connections).
• Neurotransmitter Modulation: Semax activates the brain's dopaminergic and serotonergic systems, which helps regulate mood, attention, and overall mental clarity.
• Antioxidant Effects: It exhibits antioxidant properties, protecting neurons from oxidative stress and inflammation, major contributors to cognitive decline.
• Cerebral Blood Flow: It has been shown to improve cerebral blood flow, which helps the brain function optimally, especially after injury. 

Potential Benefits and Uses

Semax has been the subject of extensive research and clinical use in Russia for various neurological and cognitive conditions. 

• Cognitive Enhancement: Users often report improved focus, memory retention, mental clarity, and attention.
• Neuroprotection and Stroke Recovery: In Russia, it is a standard treatment for ischemic stroke, transient ischemic attacks, and traumatic brain injury, as it can reduce infarct size and speed up recovery.
• Anxiety and Stress Resilience: It can help normalize the body's stress response (HPA axis) and has shown anxiolytic (anti-anxiety) and antidepressant-like effects in studies.
• Optic Nerve Health: It has shown potential in protecting the optic nerve and treating conditions like glaucoma and optic nerve atrophy. 

Safety and Regulatory Status

• Russian Status: Semax is an approved, vital, and essential prescription medication in Russia.
• US/EU Status: It is not FDA-approved for human use and faces significant regulatory restrictions in the U.S. and E.U..
• Availability: It is primarily available online as a "research chemical" for laboratory use only.
• Side Effects: It is generally well-tolerated, with a low incidence of adverse effects. Potential mild side effects include local nasal irritation, headaches, insomnia, or increased anxiety.